Arrakis Therapeutics parted ways with about 20% of its workforce last week.
CEO Michael Gilman confirmed the layoffs to the Business Journal on Monday, writing in an emailed statement that the decision was made in part because the company is prioritizing certain drug development programs.
WATCH ANYTIME FOR FREE
 |
>Stream NBC10 Boston news for free, 24/7, wherever you are. |
More on this story from Boston Business Journal
Get updates on what's happening in Boston to your inbox. Sign up for our >News Headlines newsletter.
Copyright Boston Business Journal
